Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03973918 · MORE INFO

Limitations, agreements, and source contact

Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG · Source last updated 2024-10-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Due to early termination, results are given per cohort per patient, as the data is meaningless otherwise due to small numbers. The NCI/CTEP mandated the closure of ABTC Consortium and hence why this study was terminated early
point Of Contact
email
jfisher@jhmi.edu
organization
ABTC Consortium
phone
410-955-8837
title
Director of ABTC Consortium
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Due to early termination, results are given per cohort per patient, as the data is meaningless otherwise due to small numbers. The NCI/CTEP mandated the closure of ABTC Consortium and hence why this study was terminated early
point Of Contact
email
jfisher@jhmi.edu
organization
ABTC Consortium
phone
410-955-8837
title
Director of ABTC Consortium

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice